346 related articles for article (PubMed ID: 24889748)
1. [Oral anticoagulation in chronic kidney disease with atrial fibrillation].
Expósito V; Seras M; Fernández-Fresnedo G
Med Clin (Barc); 2015 May; 144(10):452-6. PubMed ID: 24889748
[TBL] [Abstract][Full Text] [Related]
2. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Ahmad Y; Lip GY
Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
[TBL] [Abstract][Full Text] [Related]
3. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
[TBL] [Abstract][Full Text] [Related]
4. Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease.
Arnson Y; Hoshen M; Berliner-Sendrey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
Cardiology; 2020; 145(3):178-186. PubMed ID: 31955174
[TBL] [Abstract][Full Text] [Related]
5. New oral anticoagulants in patients with chronic kidney disease.
Belmar Vega L; de Francisco ALM; Bada da Silva J; Galván Espinoza L; Fernández Fresnedo G
Nefrologia; 2017; 37(3):244-252. PubMed ID: 27939514
[TBL] [Abstract][Full Text] [Related]
6. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
Potpara TS; Lip GY
Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
[TBL] [Abstract][Full Text] [Related]
7. Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease.
Potpara TS; Jokic V; Dagres N; Larsen TB; Lane DA; Hindricks G; Lip GY
Curr Med Chem; 2016; 23(19):2055-69. PubMed ID: 26861000
[TBL] [Abstract][Full Text] [Related]
8. [Oral anticoagulation in patients with atrial fibrillation and chronic kidney disease].
Sánchez-Muñoz LA; Aguilar-Flores RA; Juanatey-García A; González de Zárate-Catón S
Med Clin (Barc); 2015 May; 144(10):480. PubMed ID: 25256433
[No Abstract] [Full Text] [Related]
9. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
Salim I; Al Suwaidi J; Ghadban W; Salam AM
Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.
Bhatia HS; Bailey J; Unlu O; Hoffman K; Kim RJ
Pacing Clin Electrophysiol; 2019 Nov; 42(11):1463-1470. PubMed ID: 31599969
[TBL] [Abstract][Full Text] [Related]
11. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
Washam JB; Holmes DN; Thomas LE; Pokorney SD; Hylek EM; Fonarow GC; Mahaffey KW; Gersh BJ; Kowey PR; Ansell JE; Go AS; Reiffel JA; Freeman JV; Singer DE; Naccarelli G; Blanco R; Peterson ED; Piccini JP
J Am Heart Assoc; 2018 Sep; 7(18):e008928. PubMed ID: 30371218
[TBL] [Abstract][Full Text] [Related]
13. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.
Keskar V; Sood MM
Clin J Am Soc Nephrol; 2016 Nov; 11(11):2085-2092. PubMed ID: 27797891
[TBL] [Abstract][Full Text] [Related]
14. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
Eikelboom JW; Connolly SJ; Gao P; Paolasso E; De Caterina R; Husted S; O'Donnell M; Yusuf S; Hart RG
J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):429-35. PubMed ID: 22818021
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
16. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
[TBL] [Abstract][Full Text] [Related]
17. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
Keskar V; McArthur E; Wald R; Harel Z; Zimmerman D; Molnar AO; Garg AX; Lam NN; McCallum MK; Bota SE; Perl J; Sood MM
Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
[TBL] [Abstract][Full Text] [Related]
18. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulants in atrial fibrillation patients with chronic kidney disease.
Hart RG; Eikelboom JW; Ingram AJ; Herzog CA
Nat Rev Nephrol; 2012 Oct; 8(10):569-78. PubMed ID: 22825670
[TBL] [Abstract][Full Text] [Related]
20. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
